热门资讯> 正文

Inovio Pharmaceuticals 2025年第三季度盈利预览

2025-11-10 06:35

Inovio制药(INO) 0

Inovio Pharmaceuticals (INO) is scheduled to announce Q3 earnings results on Monday, November 10th, after market close.
The consensus EPS Estimate is -$0.48 (+46.1% Y/Y)Over the last 2 years, INO has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 4 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

More on Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)
Inovio: Back On Track With INO-3107 BLA For RRP Before End Of 2025
Inovio says FDA agrees with rolling BLA submission for rare disease asset

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。